Tweenvest Stocks

Vitura Health Limited (ASX: VIT)

Health Care · Pharmaceuticals · AU

AU$0.02

-5.00% today · -72.9% 1Y

Vitura Health Limited (ASX: VIT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.79M and employs 72 people.

Over the last twelve months the share price has lost 72.9%, trading between 0.02 and 0.07.

Tweenvest scores Vitura Health Limited across four factors: quality 60/100, value 81/100, growth 51/100. Its strongest factor is value.

VIT price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$8.79M
Revenue (TTM)
$90.74M
P/E
—
EPS
-0.01
Dividend yield
—
Beta (5Y)
-1.14
52-week high
AU$0.07
52-week low
AU$0.02
Avg volume (3M)
—
Shares outstanding
662.74M
Employees
72
Next earnings
—

About Vitura Health Limited

Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.

ISIN
AU0000266801
Founded
2018
Listed since
Nov 6, 2019
Exchange
Australian Securities Exchange
Currency
AUD
CompanyMarket capPriceDay
Marinomed Biotech AGWBAG: MARI$9.11M€——
InMed Pharmaceuticals Inc.NasdaqCM: INM$9.04M$1.36+2.26%
PEPTONIC medical AB (publ)XSAT: PMED$8.90MSkr——
Amwill Health Care LimitedBSE: 544353$8.89MRs43.00+1.18%
Mediplantex National Pharmaceutical Joint Stock CompanyHNX: MED$8.68M₫——
CalciMedica, Inc.NasdaqCM: CALC$8.67M$1.27-2.31%
PharmaCielo Ltd.TSXV: PCLO$8.52MCA$0.060.00%
Greenway Greenhouse Cannabis CorporationCNSX: GWAY$8.47MCA$0.09+12.50%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.